DOD Biotech Public Company Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was THB 117.41 million compared to THB 160.82 million a year ago. Revenue was THB 122.48 million compared to THB 161.38 million a year ago.

Net loss was THB 17.43 million compared to THB 0.708914 million a year ago. Basic loss per share from continuing operations was THB 0.034 compared to basic earnings per share from continuing operations of THB 0.012 a year ago. Diluted loss per share from continuing operations was THB 0.034 compared to diluted earnings per share from continuing operations of THB 0.012 a year ago.

Basic loss per share was THB 0.043 compared to THB 0.002 a year ago. Diluted loss per share was THB 0.043 compared to THB 0.002 a year ago.